0.6614

0.06% 0.0004

Vor Biopharma Inc (VOR)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$0.661

Offen:

$0.67

24-Stunden-Volumen:

186.02K

Relative Volume:

0.63

Marktkapitalisierung:

$89.88M

Einnahmen:

Nettoeinkommen (Verlust:

$-112.46M

KGV:

-0.4033

EPS:

-1.64

Netto-Cashflow:

$-99.89M

1W Leistung:

-8.13%

1M Leistung:

+4.32%

6M Leistung:

-17.82%

1J Leistung:

-62.42%

1-Tages-Spanne:

$0.6614

$0.6929

1-Wochen-Bereich:

$0.6505

$0.743

52-Wochen-Spanne:

$0.49

$1.87

Vor Biopharma Inc Stock (VOR) Company Profile

Firmenname

Vor Biopharma Inc

Sektor

Healthcare (1152)

Branche

Biotechnology (677)

Telefon

617-655-6580

Adresse

100 CAMBRIDGEPARK DRIVE, CAMBRIDGE

Mitarbeiter

168

Twitter

Nächster Verdiensttermin

2024-11-05

Neueste SEC-Einreichungen

VOR's Discussions on Twitter

Vergleichen Sie VOR mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
VOR Vor Biopharma Inc	0.6614	89.88M	0	-112.46M	-99.89M	-1.64
VRTX Vertex Pharmaceuticals Inc	501.15	126.96B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	605.61	65.06B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	649.67	37.54B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	259.39	32.56B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	255.77	26.40B	3.81B	-644.79M	-669.77M	-6.24

Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2022-07-26	Eingeleitet	Wedbush	Outperform
2022-04-27	Eingeleitet	Goldman	Neutral
2021-12-17	Eingeleitet	H.C. Wainwright	Buy
2021-12-03	Eingeleitet	Robert W. Baird	Outperform
2021-12-02	Eingeleitet	Oppenheimer	Outperform
2021-10-19	Eingeleitet	JMP Securities	Mkt Outperform
2021-03-25	Eingeleitet	B. Riley Securities	Buy
2021-03-03	Eingeleitet	Barclays	Overweight
2021-03-03	Eingeleitet	Evercore ISI	Outperform
2021-03-02	Eingeleitet	Goldman	Sell
2021-03-02	Eingeleitet	Stifel	Buy

Alle ansehen

Vor Biopharma Inc Aktie (VOR) Neueste Nachrichten

Apr 28, 2025

Crescent Biopharma Appoints David Lubner to Board of Directors - The Manila Times

Apr 28, 2025

Apr 26, 2025

PureTech Founded Entity Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined with a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML) - The Globe and Mail

Apr 26, 2025

Vor Biopharma faces Nasdaq delisting over low stock price - Investing.com

Apr 26, 2025

Apr 25, 2025

Vor Biopharma faces Nasdaq delisting over low stock price By Investing.com - Investing.com Nigeria

Apr 25, 2025

Apr 23, 2025

Vor Biopharma Inc’s Market Journey: Closing Strong at 0.70, Up 2.27 - DWinneX

Apr 23, 2025

Apr 21, 2025

Vor Biopharma Inc. (NYSE:VOR) Receives Average Recommendation of “Buy” from Analysts - Defense World

Apr 21, 2025

Apr 18, 2025

Shares Of Vor Biopharma Inc (NASDAQ: VOR): Are They Overvalued Compared To Others? - Stocksregister

Apr 18, 2025

Apr 17, 2025

INVESTOR ALERT: Cohen Milstein Calls on Zenas BioPharma - GlobeNewswire

Apr 17, 2025

Apr 09, 2025

Vor Biopharma stock plunges to 52-week low of $0.5 By Investing.com - Investing.com Canada

Apr 09, 2025

Vor Biopharma stock plunges to 52-week low of $0.5 - Investing.com

Apr 09, 2025

Apr 03, 2025

Vor Biopharma CMO resigns to pursue new opportunity By Investing.com - Investing.com Australia

Apr 03, 2025

Vor Biopharma stock plunges to 52-week low of $0.63 By Investing.com - Investing.com South Africa

Apr 01, 2025

Zenas BioPharma, Inc. Announcement: If You Have Suffered - GlobeNewswire

Apr 01, 2025

Virtu Financial LLC Makes New $60,000 Investment in Vor Biopharma Inc. (NYSE:VOR) - Defense World

Apr 01, 2025

Mar 31, 2025

Here's Why Vor Biopharma (NASDAQ:VOR) Must Use Its Cash Wisely - Yahoo Finance

Mar 31, 2025

Mar 27, 2025

Vor Biopharma Inc. (NYSE:VOR) Receives Average Rating of “Buy” from Analysts - Defense World

Mar 27, 2025

Mar 25, 2025

Benitec Biopharma Inc. Announces Pricing of $30 Million Common Stock Offering - GlobeNewswire

Mar 25, 2025

Mar 24, 2025

Vor Biopharma’s SWOT analysis: stock outlook amid AML treatment progress By Investing.com - Investing.com Canada

Mar 24, 2025

Vor Biopharma’s SWOT analysis: stock outlook amid AML treatment progress - Investing.com India

Mar 24, 2025

Vor Biopharma stock holds $6 target, Market Outperform rating By Investing.com - Investing.com South Africa

Mar 24, 2025

Vor Biopharma stock holds $6 target, Market Outperform rating - Investing.com India

Mar 24, 2025

Citizens JMP Reiterates Market Outperform Rating on Vor Biopharma, Inc. (VOR) - StreetInsider

Mar 24, 2025

Mar 23, 2025

Stifel Nicolaus Has Lowered Expectations for Vor Biopharma (NYSE:VOR) Stock Price - Defense World

Mar 23, 2025

Oppenheimer Reiterates “Outperform” Rating for Vor Biopharma (NYSE:VOR) - Defense World

Mar 23, 2025

Mar 22, 2025

Wedbush Reaffirms Outperform Rating for Vor Biopharma (NYSE:VOR) - Defense World

Mar 22, 2025

Stifel cuts Vor Biopharma stock target to $5, maintains Buy rating - Investing.com Canada

Mar 22, 2025

Mar 21, 2025

Analysts Offer Insights on Healthcare Companies: Vor Biopharma (VOR), Skye Bioscience (SKYE) and Bristol-Myers Squibb (BMY) - The Globe and Mail

Mar 21, 2025

Stifel cuts Vor Biopharma stock target to $5, maintains Buy rating By Investing.com - Investing.com South Africa

Mar 21, 2025